Ruf, R. Et Al. 2004. Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.15, no.3 , 722-732.

Ruf, R., Lichtenberger, A., Karle, S., Haas, J., Anacleto, F., Schultheiss, M., ... Zalewski, I.(2004). Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.15, no.3, 722-732.

Ruf, RG Et Al. "Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome," JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.15, no.3, 722-732, 2004

Ruf, RG Et Al. "Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome." JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.15, no.3, pp.722-732, 2004

Ruf, R. Et Al. (2004) . "Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome." JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.15, no.3, pp.722-732.

@article{article, author={RG Ruf Et Al. }, title={Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome}, journal={JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY}, year=2004, pages={722-732} }